KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
558.00
+15.00 (2.76%)
At close: Dec 5, 2025
KMPHARMACEUTICAL Revenue
KMPHARMACEUTICAL had revenue of 4.38B KRW in the quarter ending September 30, 2025, with 32.66% growth. This brings the company's revenue in the last twelve months to 15.09B, up 3.76% year-over-year. In the year 2024, KMPHARMACEUTICAL had annual revenue of 14.47B, down -18.54%.
Revenue (ttm)
15.09B
Revenue Growth
+3.76%
P/S Ratio
1.03
Revenue / Employee
260.22M
Employees
58
Market Cap
15.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.47B | -3.29B | -18.54% |
| Dec 31, 2023 | 17.77B | 2.14B | 13.68% |
| Dec 31, 2022 | 15.63B | -7.07B | -31.15% |
| Dec 31, 2021 | 22.71B | -223.00M | -0.97% |
| Dec 31, 2020 | 22.93B | 2.59B | 12.73% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
| Mar 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |